1066.HK

Shandong Weigao Group Medical Polymer Company Limited 1066.HK

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 1066.HK 3933.HK 0512.HK 6127.HK 9688.HK 0853.HK 3320.HK 9606.HK 6855.HK 2276.HK
6M 2.90 % 3.94 % 47.66 % 93.05 % -3.16 % 90.27 % -2.26 % 49.09 % 84.39 % 73.16 %
YTD 29.68 % 7.68 % 78.48 % 111.65 % 13.00 % 110.77 % -13.61 % 59.71 % 56.57 % 69.42 %
1Y 13.83 % 23.64 % 75.43 % 110.00 % 2.70 % 94.11 % -18.91 % 59.71 % 44.36 % 155.34 %
3Y -52.75 % 276.57 % 112.14 % -11.93 % -4.21 % -23.84 % -18.49 % 59.71 % 354.85 % 565.87 %
5Y -62.23 % 93.26 % 26.70 % -62.42 % -68.00 % -56.53 % 21.74 % 59.71 % 145.08 % 761.98 %
10Y 2.71 % 201.60 % 2 276.40 % -62.42 % -63.80 % 279.39 % -47.17 % 59.71 % 82.18 % 761.98 %
From the beginning 3 145.71 % 298.19 % 3 505.15 % -62.42 % -63.80 % 51.03 % -47.17 % 59.71 % 82.18 % 761.98 %

Dividend

Shandong Weigao Group Medical Polymer Company Limited

The United Laboratories International Holdings Limited

Grand Pharmaceutical Group Limited

Joinn Laboratories(China)Co.,Ltd.

MicroPort Scientific Corporation

China Resources Pharmaceutical Group Limited

Shanghai Conant Optical Co., Ltd.